From: Lung resection surgery in Jehovah’s Witness patients: a 20-year single-center experience
Gender | Age | Year of operation | Type of surgery | Initial operative approach | Convert to open | Diagnosis | Neoadjuvant therapy | Lymph node sampling | Pathologic stage | Adjuvant chemotherapy | Adjuvant radiation therapy | Recurrence | Time to recurrence (months) | Reoperation | Length of survival (months) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
F | 70 | 2005 | Left upper lobe wedge resection | VATS | No | Large cell neuroendocrine carcinoma | No | Not done | IA | No | No | None | N/A | None | 184 (alive) |
F | 73 | 2007 | Left upper lobectomy | Thoracotomy | N/A | Adenocarcinoma | Yes | 5, 7, 9L | IIIA | Yes | No | None | N/A | None | 143 |
F | 65 | 2009 | Right lower lobectomy | VATS | Yes | Adenocarcinoma | No | 4R, 7, 9R, 11R | IIB | Yes | No | Distant | 16 | Thoracotomy, LLL wedge resection MLND | 45 |
F | 47 | 2009 | Left lower lobectomy | VATS | Yes | Adenocarcinoma | No | 5, 7, 10L, 11L | IIB | No | No | Distant | 18 | VATS, RUL wedge resection | 87 |
F | 74 | 2012 | Left lower lobectomy | VATS | No | Adenocarcinoma | No | 5, 6, 9L, 11L | IB | No | No | 47 | Left VATS, pleural biopsy, TPC placement | 65 | |
M | 73 | 2019 | Left upper lobectomy | VATS | Yes | Adenocarcinoma | Yes | 5, 7, 8L, 9L, 11L, 12L | IIA | N/A | N/A | Distant | N/A | None | 0 |
F | 58 | 2020 | Right lower segmentectomy | VATS | No | Adenocarcinoma | No | 4R, 7, 9R, 10R, 11R | IA | No | No | None | N/A | None | 14 (alive) |